{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:21:12Z","timestamp":1769509272298,"version":"3.49.0"},"reference-count":47,"publisher":"The Journal of Rheumatology","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2013,11]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>The prevalence of metabolic syndrome (MetS) tends to be high among rheumatic patients, and cardiovascular disease is the leading cause of death in these conditions. We aimed to determine the prevalence of MetS in patients with Takayasu arteritis (TA) and its association with risk factors and adipokine and cytokine levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>A cross-sectional study was conducted in 45 consecutive women with TA and 47 healthy controls matched by age and body mass index.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>The prevalence of MetS (International Diabetes Federation\/American Heart Association criteria) was higher in TA compared to controls (33.34 vs 8.51%, p = 0.003). Patients with TA had a higher frequency of hypertension (p &lt; 0.001) and dyslipidemia (p = 0.001) and higher levels of insulin (p = 0.021), homeostasis model assessment index (p = 0.024), apolipoprotein E (p = 0.029), resistin (p = 0.018), and C-reactive protein (CRP, p &lt; 0.001) compared to healthy subjects, with similar levels of adiponectin and plasminogen activator inhibitor-1 (PAI-1; p &gt; 0.05). Further analysis of patients with TA with and without MetS revealed a higher frequency of overweight\/obesity (66.66 vs 26.66%, p = 0.022), higher Framingham score \u2265 1 (p = 0.032), and lower adiponectin levels (20.37 \u00b1 21.16 vs 38.64 \u00b1 22.62 \u03bcg\/ml, p = 0.022) in the patients with MetS. No differences were found regarding disease duration, activity, glucocorticoid use, resistin, and PAI-1 levels in the 2 groups of patients with TA (p &gt; 0.05). Patients with and without MetS showed no differences in cytokine levels [interleukin 12 (IL-12, IL-1a, IL-6) and tumor necrosis factor-\u03b1]. IL-6 had a positive Pearson correlation with CRP only in TA patients with MetS (r = 0.57; p = 0.050).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>A high prevalence of MetS was observed in patients with TA and this comorbidity seems to identify a subgroup of overweight\/obese patients with high cardiovascular risk without a significant association with disease status. Further longitudinal studies are necessary to observe the effects of controlling this modifiable risk factor in the quality of life and survival of patients with TA.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.130162","type":"journal-article","created":{"date-parts":[[2013,9,16]],"date-time":"2013-09-16T00:14:23Z","timestamp":1379290463000},"page":"1897-1904","source":"Crossref","is-referenced-by-count":40,"title":["High Prevalence of Metabolic Syndrome in Takayasu Arteritis: Increased Cardiovascular Risk and Lower Adiponectin Serum Levels"],"prefix":"10.3899","volume":"40","author":[{"given":"Thiago Ferreira","family":"da Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maur\u00edcio","family":"Levy-Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eloisa","family":"Bonf\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa Maria R.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2013,9,15]]},"reference":[{"key":"2018112909320817000_40.11.1897.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.01.001"},{"key":"2018112909320817000_40.11.1897.2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S"},{"key":"2018112909320817000_40.11.1897.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2005.12.006"},{"key":"2018112909320817000_40.11.1897.4","first-page":"841","article-title":"Taking mortality in rheumatic arthritis seriously \u2014 predictive markers, socioeconomic status and comorbidity","volume":"13","author":"Pincus","year":"1986","journal-title":"J Rheumatol"},{"key":"2018112909320817000_40.11.1897.5","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009122"},{"key":"2018112909320817000_40.11.1897.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2012.12.004"},{"key":"2018112909320817000_40.11.1897.7","doi-asserted-by":"publisher","DOI":"10.2337\/db06-0263"},{"key":"2018112909320817000_40.11.1897.8","doi-asserted-by":"publisher","DOI":"10.1100\/2011\/290142"},{"key":"2018112909320817000_40.11.1897.9","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1017\/S1047951108002060","article-title":"Takayasu\u2019s disease: a review","volume":"18","author":"Tann","year":"2008","journal-title":"Cardiol Young"},{"key":"2018112909320817000_40.11.1897.10","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-009-1153-8"},{"key":"2018112909320817000_40.11.1897.11","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/art.1780330811","article-title":"The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis","volume":"33","author":"Arend","year":"1990","journal-title":"Arthritis Rheum"},{"key":"2018112909320817000_40.11.1897.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67402-8"},{"key":"2018112909320817000_40.11.1897.13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486"},{"key":"2018112909320817000_40.11.1897.14","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-120-11-199406010-00004"},{"key":"2018112909320817000_40.11.1897.15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei045"},{"key":"2018112909320817000_40.11.1897.16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.192644"},{"key":"2018112909320817000_40.11.1897.17","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/clinchem\/29.6.1075","article-title":"Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency","volume":"29","author":"Siedel","year":"1983","journal-title":"Clin Chem"},{"key":"2018112909320817000_40.11.1897.18","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/clinchem\/25.4.596","article-title":"Comparison of current methods for high density lipoprotein cholesterol quantification","volume":"25","author":"Warnick","year":"1979","journal-title":"Clin Chem"},{"key":"2018112909320817000_40.11.1897.19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedwald","year":"1972","journal-title":"Clin Chem"},{"key":"2018112909320817000_40.11.1897.20","first-page":"1545","article-title":"Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus","volume":"33","author":"Sada","year":"2006","journal-title":"J Rheumatol"},{"key":"2018112909320817000_40.11.1897.21","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280883"},{"key":"2018112909320817000_40.11.1897.22","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.43.453"},{"key":"2018112909320817000_40.11.1897.23","doi-asserted-by":"publisher","DOI":"10.2337\/db11-1300"},{"key":"2018112909320817000_40.11.1897.24","doi-asserted-by":"publisher","DOI":"10.1186\/1758-5996-4-20"},{"key":"2018112909320817000_40.11.1897.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2007.07.097"},{"key":"2018112909320817000_40.11.1897.26","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.074583"},{"key":"2018112909320817000_40.11.1897.27","doi-asserted-by":"publisher","DOI":"10.1177\/0961203308093554"},{"key":"2018112909320817000_40.11.1897.28","first-page":"32","article-title":"Prevalence of and risk factors for the metabolic syndrome in women with systemic lupus erythematosus","volume":"26","author":"Bultink","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909320817000_40.11.1897.29","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.053488"},{"key":"2018112909320817000_40.11.1897.30","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/34.6.54"},{"key":"2018112909320817000_40.11.1897.31","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21701"},{"key":"2018112909320817000_40.11.1897.32","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes345"},{"key":"2018112909320817000_40.11.1897.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.04.018"},{"key":"2018112909320817000_40.11.1897.34","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.9.5789"},{"key":"2018112909320817000_40.11.1897.35","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-011-0468-x"},{"key":"2018112909320817000_40.11.1897.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2010.05.008"},{"key":"2018112909320817000_40.11.1897.37","doi-asserted-by":"publisher","DOI":"10.1186\/ar2366"},{"key":"2018112909320817000_40.11.1897.38","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.054734"},{"key":"2018112909320817000_40.11.1897.39","first-page":"157","article-title":"Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity","volume":"43","author":"Stofkova","year":"2009","journal-title":"Endocr Regul"},{"key":"2018112909320817000_40.11.1897.40","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20488"},{"key":"2018112909320817000_40.11.1897.41","first-page":"1532","article-title":"Association of adiponectin and metabolic syndrome in women","volume":"16","author":"Sanjari","year":"2011","journal-title":"J Res Med Sci"},{"key":"2018112909320817000_40.11.1897.42","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.081253"},{"key":"2018112909320817000_40.11.1897.43","doi-asserted-by":"publisher","DOI":"10.1177\/0961203309105876"},{"key":"2018112909320817000_40.11.1897.44","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2011.626443"},{"key":"2018112909320817000_40.11.1897.45","doi-asserted-by":"publisher","DOI":"10.1186\/ar2578"},{"key":"2018112909320817000_40.11.1897.46","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.1.55"},{"key":"2018112909320817000_40.11.1897.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2012.01.035"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.130162","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T02:56:14Z","timestamp":1596509774000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.130162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,15]]},"references-count":47,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,1]]},"published-print":{"date-parts":[[2013,11]]}},"alternative-id":["10.3899\/jrheum.130162"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.130162","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,15]]}}}